Stifel Reiterates Hold Rating on Fate Therapeutics (FATE)

Go back to Stifel Reiterates Hold Rating on Fate Therapeutics (FATE)

Form SC 13G/A FATE THERAPEUTICS INC Filed by: Point72 Asset Management, L.P.

November 14, 2024 7:50 PM EST

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ... More